- Home
- CRDO vs CORT Comparison
CRDO vs CORT Comparison
Compare CRDO & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDO
- CORT
- Stock Information
- Founded
- CRDO 2008
- CORT 1998
- Country
- CRDO Cayman Islands
- CORT United States
- Employees
- CRDO N/A
- CORT N/A
- Industry
- CRDO Semiconductors
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- CRDO Technology
- CORT Health Care
- Exchange
- CRDO Nasdaq
- CORT Nasdaq
- Market Cap
- CRDO 7.3B
- CORT 7.1B
- IPO Year
- CRDO 2022
- CORT N/A
- Fundamental
- Price
- CRDO $60.13
- CORT $75.08
- Analyst Decision
- CRDO Strong Buy
- CORT Strong Buy
- Analyst Count
- CRDO 10
- CORT 4
- Target Price
- CRDO $68.00
- CORT $142.00
- AVG Volume (30 Days)
- CRDO 3.9M
- CORT 1.3M
- Earning Date
- CRDO 06-02-2025
- CORT 05-05-2025
- Dividend Yield
- CRDO N/A
- CORT N/A
- EPS Growth
- CRDO N/A
- CORT 8.36
- EPS
- CRDO 0.03
- CORT 1.14
- Revenue
- CRDO $327,532,000.00
- CORT $685,446,000.00
- Revenue This Year
- CRDO $125.51
- CORT $35.85
- Revenue Next Year
- CRDO $58.82
- CORT $35.22
- P/E Ratio
- CRDO $1,949.77
- CORT $65.80
- Revenue Growth
- CRDO 99.38
- CORT 30.93
- 52 Week Low
- CRDO $16.98
- CORT $25.35
- 52 Week High
- CRDO $86.69
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- CRDO 73.60
- CORT 57.68
- Support Level
- CRDO $57.49
- CORT $68.86
- Resistance Level
- CRDO $61.44
- CORT $73.36
- Average True Range (ATR)
- CRDO 2.53
- CORT 3.26
- MACD
- CRDO 1.72
- CORT 0.12
- Stochastic Oscillator
- CRDO 93.85
- CORT 95.28
About CRDO Credo Technology Group Holding Ltd
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.